Akebia Therapeutics, Inc. (AKBA)
1.625
+0.04
(+2.85%)
USD |
NASDAQ |
Dec 10, 16:00
1.60
-0.02
(-1.54%)
After-Hours: 17:53
Akebia Therapeutics Market Cap: 431.22M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 146.55B |
| Plus Therapeutics, Inc. | 92.08M |
| Ironwood Pharmaceuticals, Inc. | 600.28M |
| Pyxis Oncology, Inc. | 266.18M |
| Karyopharm Therapeutics, Inc. | 109.81M |
Market Cap Related Metrics
| PS Ratio | 1.815 |
| Price to Book Value | 10.37 |
| Price to Free Cash Flow | 12.70 |
| Price | 1.625 |
| Earnings Yield | -4.68% |
| Operating PE Ratio | 23.03 |